Heart palpitations do not appear as a primary listed side effect in these datasets
If the active ingredient degrades because of improper storage, drawing exactly 10 units may deliver less than the expected milligram amount because some of the semaglutide molecules have broken down
However, these medications should be stopped 23 months before pregnancy due to limited safety data during pregnancy
Safety Warning For healthy individuals 18 years and older
The report highlights early metabolic studies, selected clinical trials, and certain double-blind placebo-controlled investigations that examined markers such as: blood sugar regulation insulin sensitivity cholesterol levels impaired glucose tolerance adipose tissue activity fat release and lipolytic activity While these studies generated interest in AOD-9604 as a potential anti-obesity drug candidate , the report stresses that no authority recognizes it as an active treatment for obesity, weight loss, or human use and emphasizes that it remains designated strictly for research use
NICE guidance suggests discontinuing Wegovy if patients have not achieved at least 5% weight loss from baseline after 6 months at the maintenance dose
